Evidence map›Paper›PMID 37873403›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Microbiome-based risk prediction in incident heart failure: a community challenge.

Pande Putu Erawijantari, Ece Kartal, José Liñares-Blanco, Teemu D Laajala, Lily Elizabeth Feldman, FINRISK Microbiome DREAM Challenge and ML4Microbiome Communities, Pedro Carmona-Saez, Rajesh Shigdel, Marcus Joakim Claesson, Randi Jacobsen Bertelsen and 15 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 9 countries.

Pande Putu ErawijantariDepartment of Computing, Faculty of Technology, University of Turku, Turku, Finland.
Ece KartalHeidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany.
José Liñares-BlancoHeidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany.
Teemu D LaajalaDepartment of Mathematics and Statistics, Faculty of Science, University of Turku, Finland.
Lily Elizabeth FeldmanDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
FINRISK Microbiome DREAM Challenge and ML4Microbiome Communities
Pedro Carmona-SaezGENYO. Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, PTS Granada, Avenida de la Ilustración 114, 18016, Granada, Spain.
Rajesh ShigdelDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Marcus Joakim ClaessonAPC Microbiome Ireland, University College Cork, T12 YT20 Cork, Ireland.
Randi Jacobsen BertelsenDepartment of Clinical Science, University of Bergen, Bergen, Norway.
David Gomez-CabreroTranslational Bioinformatics Unit, Navarrabiomed, Public University of Navarra, IDISNA, Pamplona, Spain.
Samuel MinotData Core, Shared Resources, Fred Hutchinson Cancer Center. Seattle, WA. USA.
Jacob AlbrechtSage Bionetworks, Seattle, WA. USA.
Verena ChungSage Bionetworks, Seattle, WA. USA.
Michael InouyeCambridge Baker Systems Genomics Initiative, Baker Heart & Diabetes Institute, Melbourne, Victoria, Australia.
Pekka JousilahtiDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Jobst-Hendrik SchultzDepartment of General Internal Medicine & Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany.
Hans-Christoph FriederichDepartment of General Internal Medicine & Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany.
Rob KnightJacobs School of Engineering, University of California San Diego, La Jolla, CA. USA.
Veikko SalomaaDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Teemu NiiranenDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Aki S HavulinnaDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
Julio Saez-RodriguezHeidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany.
Rebecca T LevinsonHeidelberg University, Faculty of Medicine, and Heidelberg University Hospital, Institute for Computational Biomedicine, Bioquant, Heidelberg, Germany.
Leo LahtiDepartment of Computing, Faculty of Technology, University of Turku, Turku, Finland.
Heidelberg University · DEUniversity of Turku · FISage Bionetworks · USUniversidad de Granada · ESUniversity College Cork · IEBaker Heart and Diabetes Institute · AUFred Hutch Cancer Center · USNavarrabiomed · ESUniversity of California San Diego · USUniversity of Colorado Anschutz Medical Campus · US

Funding

PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1M
NIGMS NIH HHS T32 GM007635
6 · The paper itself

Abstract

Heart failure (HF) is a major public health problem. Early identification of at-risk individuals could allow for interventions that reduce morbidity or mortality. The community-based FINRISK Microbiome DREAM challenge (synapse.org/finrisk) evaluated the use of machine learning approaches on shotgun metagenomics data obtained from fecal samples to predict incident HF risk over 15 years in a population cohort of 7231 Finnish adults (FINRISK 2002, n=559 incident HF cases). Challenge participants used synthetic data for model training and testing. Final models submitted by seven teams were evaluated in the real data. The two highest-scoring models were both based on Cox regression but used different feature selection approaches. We aggregated their predictions to create an ensemble model. Additionally, we refined the models after the DREAM challenge by eliminating phylum information. Models were also evaluated at intermediate timepoints and they predicted 10-year incident HF more accurately than models for 5- or 15-year incidence. We found that bacterial species, especially those linked to inflammation, are predictive of incident HF. This highlights the role of the gut microbiome as a potential driver of inflammation in HF pathophysiology. Our results provide insights into potential modeling strategies of microbiome data in prospective cohort studies. Overall, this study provides evidence that incorporating microbiome information into incident risk models can provide important biological insights into the pathogenesis of HF.

Identifiers

PMID37873403
PMCPMC10593042
OpenAlexW4387580913

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.